Last Friday, Neuro-Biotech Corp. (PINK:MRES) stock price went through the roof, after it advanced by merely 145.45% and reached a share price of $0.027. Volume surged up as well, reaching 7.5 million traded shares.
One of the reasons for the stock upsurge could have been its promotion, which took place the same day. On the other hand, it could have been the PR news of Oct. 29, which didn’t feature anything significant, only a description of the company’s NeuroChAT test.
Therefore, the impressive…